Literature DB >> 819641

Pseudomonas carrier rates of patients with cystic fibrosis and of members of their families.

L R Laraya-Cuasay, K R Cundy, N N Huang.   

Abstract

The majority (86.6%) of patients with cystic fibrosis were found to be carriers of Pseudomonas aeruginosa. None of them, however, carried P. aeruginosa in their nares. In contrast, none of the non-CF family members of the patients with CF were carriers of P. aeruginosa. For example, only 4 of 468 cultures from skin, throat, and nares of the family members were positive for P. aeruginosa. Isolations of P. aeruginosa from the same CF patients were often of the same pyocine type. No specific pyocine type of P. aeruginosa was predominant in patients with CF. Isolations of P. aeruginosa from siblings with CF may or may not be of the same pyocine type as that of the family proband. Colonization of a patient with CF by P. aeruginosa is not a threat to the non-CF members of the family.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 819641     DOI: 10.1016/s0022-3476(76)80920-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia.

Authors:  S T Hingley; A T Hastie; F Kueppers; M L Higgins; G Weinbaum; T Shryock
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

2.  Pseudomonas aeruginosa exoenzyme S is an adhesion.

Authors:  N R Baker; V Minor; C Deal; M S Shahrabadi; D A Simpson; D E Woods
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

Review 3.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

4.  Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.

Authors:  J E Pennington; W F Hickey; L L Blackwood; M A Arnaut
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

5.  A tracheal culture model of respiratory tract infection with Pseudomonas aeruginosa.

Authors:  N R Baker; Y Tao
Journal:  In Vitro       Date:  1982-04

6.  Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.

Authors:  C Wolz; G Kiosz; J W Ogle; M L Vasil; U Schaad; K Botzenhart; G Döring
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

7.  Protease production by Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  A T Hastie; S T Hingley; F Kueppers; M L Higgins; C S Tannenbaum; G Weinbaum
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

8.  Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition.

Authors:  M A Luzar; M J Thomassen; T C Montie
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa.

Authors:  M A Luzar; T C Montie
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

10.  Partial purification and characterization of a polymannuronic acid depolymerase produced by a mucoid strain of Pseudomonas aeruginosa isolated from a patient with cystic fibrosis.

Authors:  W M Dunne; F L Buckmire
Journal:  Appl Environ Microbiol       Date:  1985-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.